These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21892742)
1. Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood-tumor barrier permeability. Ma T; Liu L; Wang P; Xue Y J Neurooncol; 2012 Jan; 106(2):291-301. PubMed ID: 21892742 [TBL] [Abstract][Full Text] [Related]
2. RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin. Ma T; Xue Y J Mol Neurosci; 2010 Sep; 42(1):67-73. PubMed ID: 20369389 [TBL] [Abstract][Full Text] [Related]
3. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB. Xie H; Xue YX; Liu LB; Liu YH; Wang P J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway. Xue Y; He JT; Zhang KK; Chen LJ; Wang Q; Xie XL Biochem Biophys Res Commun; 2019 Feb; 509(2):395-401. PubMed ID: 30594393 [TBL] [Abstract][Full Text] [Related]
5. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. Liu LB; Xue YX; Liu YH; Wang YB J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction. Zhang Z; Xia C; Xue Y; Liu Y J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437 [TBL] [Abstract][Full Text] [Related]
7. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway. Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255 [TBL] [Abstract][Full Text] [Related]
8. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526 [TBL] [Abstract][Full Text] [Related]
9. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway. Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310 [TBL] [Abstract][Full Text] [Related]
10. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism. Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443 [TBL] [Abstract][Full Text] [Related]
11. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. Li Z; Liu YH; Xue YX; Liu LB; Wang P J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886 [TBL] [Abstract][Full Text] [Related]
12. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin. Liu LB; Liu XB; Ma J; Liu YH; Li ZQ; Ma T; Zhao XH; Xi Z; Xue YX Biochem Biophys Res Commun; 2015 Aug; 464(1):118-25. PubMed ID: 26106824 [TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Feng S; Zou L; Wang H; He R; Liu K; Zhu H Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623 [TBL] [Abstract][Full Text] [Related]
14. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651 [TBL] [Abstract][Full Text] [Related]
15. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase. Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438 [TBL] [Abstract][Full Text] [Related]
16. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743 [TBL] [Abstract][Full Text] [Related]
17. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway. Liu LB; Xue YX; Liu YH J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088 [TBL] [Abstract][Full Text] [Related]
18. NMDA mediates disruption of blood-brain barrier permeability via Rho/ROCK signaling pathway. Yu Y; Wu Y; Wei J; Huang F; Mao F; Nong W; Cao X; Huang W Neurochem Int; 2022 Mar; 154():105278. PubMed ID: 35017026 [TBL] [Abstract][Full Text] [Related]
19. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression. Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344 [TBL] [Abstract][Full Text] [Related]
20. Oligomeric Tau-induced oxidative damage and functional alterations in cerebral endothelial cells: Role of RhoA/ROCK signaling pathway. Hossen F; Sun GY; Lee JC Free Radic Biol Med; 2024 Aug; 221():261-272. PubMed ID: 38815773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]